Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that on February 26, 2026, it purchased 87,500 of its ordinary shares for approximately £1.2 million as part of its $250 million share repurchase program. The company intends to cancel these repurchased shares, which brings its total treasury shares to 12,833,233 and its issued shares to 234,632,186, resulting in a total of 234,632,186 voting rights. The average price paid per share was 1,394.36 pence, with prices ranging from 1,355.00 pence to 1,465.00 pence.

Disclaimer*

UK 100

Latest directors dealings